As early as the mid-30s, women start to experience declines in fertility. Worm research finds that new drug may extend woman’s fertility by 6 years.
Administration of Cathepsin B inhibitor halfway through the worms' reproductive period, could extend the worms' egg quality, revealed study. "One of the most important characteristics of ageing is the loss of reproductive ability in mid-adulthood," said Coleen Murphy, Professor at the Princeton University in the US.
‘Novel drug that extends egg viability in worms has been identified. The new finding could potentially extend a woman's fertility by three to six years.’
"As early as the mid-30s, women start to experience declines in fertility, increased rates of miscarriage and maternal age-related birth defects. All of these problems are thought to be caused by declining egg quality, rather than a lack of eggs," Murphy added. The team used a microscopic worm, Caenorhabditis elegans (C.elegans), as they share many of the genes as humans, including longevity genes.
They found that a group of proteins called Cathepsin B proteases "downregulate", or lead to lower-quality oocytes (unfertilised eggs), as one ages.
In the study, published in the journal Current Biology, when the team administered the Cathepsin B inhibitor halfway through the worms' reproductive period, they found that even a late administration of the drug could extend the worms' egg quality.
Another experiment that knocked out the cathepsin B genes entirely succeeded in extending worms' fertility by about 10 per cent.
Advertisement
Reproductive decline is a hallmark of ageing, but despite its prevalence, interventions to slow the loss of reproductive capacity are lacking, researchers said.
Advertisement
Source-IANS